Susquehanna International Group, LLP Cel Sci Corp Transaction History

Susquehanna International Group, LLP

$641 Billion
Q4 2024

A detailed history of Susquehanna International Group, LLP transactions in Cel Sci Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 80,874 shares of CVM stock, worth $32,349. This represents 0.0% of its overall portfolio holdings.

Number of Shares

80,874

Previous 80,345 0.66%

Holding current value

$32,349

Previous $85,000 62.35%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.4 - $1.11 $211 - $587	529 Added 0.66%	80,874 $32,000
Q3 2024 Nov 14, 2024	SELL	$1.05 - $1.5 $18,434 - $26,335	-17,557 Reduced 17.93%	80,345 $85,000
Q2 2024 Aug 15, 2024	SELL	$1.11 - $1.85 $633,906 - $1.06 Million	-571,087 Reduced 85.37%	97,902 $113,000
Q1 2024 May 07, 2024	BUY	$1.63 - $3.08 $457,501 - $864,482	280,676 Added 72.28%	668,989 $1.28 Million
Q4 2023 Feb 14, 2024	BUY	$1.07 - $3.07 $351,594 - $1.01 Million	328,593 Added 550.22%	388,313 $1.06 Million
Q3 2023 Nov 14, 2023	SELL	$1.17 - $2.86 $140,832 - $344,258	-120,370 Reduced 66.84%	59,720 $74,000
Q2 2023 Aug 11, 2023	SELL	$2.11 - $2.83 $60,875 - $81,648	-28,851 Reduced 13.81%	180,090 $434,000
Q1 2023 May 16, 2023	SELL	$2.17 - $3.13 $46,709 - $67,373	-21,525 Reduced 9.34%	208,941 $484,000
Q4 2022 Feb 14, 2023	SELL	$1.99 - $3.52 $175,277 - $310,038	-88,079 Reduced 27.65%	230,466 $541,000
Q3 2022 Nov 14, 2022	SELL	$3.09 - $5.23 $236,159 - $399,713	-76,427 Reduced 19.35%	318,545 $984,000
Q2 2022 Aug 15, 2022	BUY	$2.58 - $4.99 $420,712 - $813,704	163,067 Added 70.32%	394,972 $1.78 Million
Q1 2022 May 16, 2022	SELL	$3.93 - $7.7 $568,022 - $1.11 Million	-144,535 Reduced 38.4%	231,905 $911,000
Q4 2021 Feb 14, 2022	SELL	$7.1 - $12.82 $3.3 Million - $5.95 Million	-464,198 Reduced 55.22%	376,440 $2.67 Million
Q3 2021 Nov 15, 2021	SELL	$7.64 - $12.49 $443,853 - $725,619	-58,096 Reduced 6.46%	840,638 $9.24 Million
Q2 2021 Aug 11, 2021	BUY	$8.68 - $27.49 $1.42 Million - $4.51 Million	164,045 Added 22.33%	898,734 $7.8 Million
Q1 2021 May 17, 2021	BUY	$12.0 - $27.64 $937,524 - $2.16 Million	78,127 Added 11.9%	734,689 $11.2 Million
Q4 2020 Feb 16, 2021	SELL	$11.05 - $16.62 $514,565 - $773,943	-46,567 Reduced 6.62%	656,562 $7.66 Million
Q3 2020 Nov 16, 2020	BUY	$11.69 - $14.54 $2.56 Million - $3.18 Million	218,867 Added 45.2%	703,129 $8.97 Million
Q2 2020 Aug 14, 2020	SELL	$9.75 - $17.6 $3.52 Million - $6.35 Million	-361,054 Reduced 42.71%	484,262 $7.23 Million
Q1 2020 May 15, 2020	BUY	$7.54 - $17.05 $6.28 Million - $14.2 Million	833,101 Added 6820.31%	845,316 $9.76 Million
Q3 2019 Nov 14, 2019	SELL	$6.0 - $9.6 $733,488 - $1.17 Million	-122,248 Reduced 90.92%	12,215 $109,000
Q2 2019 Aug 16, 2019	BUY	$3.77 - $8.67 $8,237 - $18,943	2,185 Added 1.65%	134,463 $1.13 Million
Q2 2019 Aug 14, 2019	SELL	$3.77 - $8.67 $42,050 - $96,705	-11,154 Reduced 7.78%	132,278 $1.11 Million
Q3 2017 Nov 14, 2017	BUY	$1.59 - $3.0 $228,056 - $430,296	143,432	143,432 $238,000

Others Institutions Holding CVM

# of Institutions

Shares Held

6.95M

Call Options Held

38.3K

Put Options Held

184K

View Full List

About CEL SCI CORP

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $17.3M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

More about CVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Cel Sci Corp Transaction History